Cited by 57Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment ResearchAdvanced MRI Techniques and Applications

Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: a longitudinal arterial spin labeling study

Open access
Dopper, Elise G.P., Chalos, Vicky, Ghariq, Eidrees, den Heijer, Tom, Hafkemeijer, Anne, Jiskoot, Lize C., de Koning, Inge, Seelaar, Harro +4 more·2016·NeuroImage: Clinical

Abstract

OBJECTIVE: Frontotemporal dementia (FTD) is characterized by behavioral disturbances and language problems. Familial forms can be caused by genetic defects in microtubule-associated protein tau (MAPT), progranulin (GRN), and C9orf72. In light of upcoming clinical trials with potential disease-modifying agents, the development of sensitive biomarkers to evaluate such agents in the earliest stage of FTD is crucial. In the current longitudinal study we used arterial spin labeling MRI (ASL) in presymptomatic carriers of MAPT and GRN mutations to investigate early changes in cerebral blood flow (CBF). METHODS: Healthy first-degree relatives of patients with a MAPT or GRN mutation underwent ASL at baseline and follow-up after two years. We investigated cross-sectional and longitudinal differences in CBF between mutation carriers (n = 34) and controls without a mutation (n = 31). RESULTS: GRN mutation carriers showed significant frontoparietal hypoperfusion compared with controls at follow-up, whereas we found no cross-sectional group differences in the total study group or the MAPT subgroup. Longitudinal analyses revealed a significantly stronger decrease in CBF in frontal, temporal, parietal, and subcortical areas in the total group of mutation carriers and the GRN subgroup, with the strongest decrease in two mutation carriers who converted to clinical FTD during follow-up. INTERPRETATION: We demonstrated longitudinal alterations in CBF in presymptomatic FTD independent of grey matter atrophy, with the strongest decrease in individuals that developed symptoms during follow-up. Therefore, ASL could have the potential to serve as a sensitive biomarker of disease progression in the presymptomatic stage of FTD in future clinical trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nicl.2016.08.001

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A genetic ASL study in FTD patients showed that a specific pattern of frontal, temporal, parietal and subcortical CBF decrease accompanied clinical conversion from pre-symptomatic to symptomatic stages in MAPT and GRN mutation carriers over 2 years.

    “A genetic study on arterial spin labelling (ASL) in FTD patients, measuring cerebral blood flow (CBF), showed that a specific pattern of frontal, temporal, parietal and subcortical CBF decrease accompanied the clinical conversion from pre-symptomatic to symptomatic stages in MAPT and GRN mutation carriers over 2 years (Dopper et al., 2016).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dopper, E. G. P., Chalos, V., Ghariq, E., den Heijer, T., Hafkemeijer, A., Jiskoot, L. C., de Koning, I., Seelaar, H., van Minkelen, R., van Osch, M. J. P., Rombouts, S. A. R. B., & van Swieten, J. C.
Affiliations
  • Leiden University Medical Center (NL)
  • Erasmus MC (NL)
  • Leiden University (NL)
Venue
NeuroImage: Clinical
Publisher
Elsevier BV
Published
2016-02
Volume
12
Pages
460-465
ISSN
2213-1582 (ISSN-L)
OpenAlex
W2506919437
Cited by
57
References
56
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 8 · 2021: 8 · 2020: 11 · 2019: 4 · 2018: 6 · 2017: 5
FWCI
3.76
Type
journal article
Language
en
Open access
Locations
  • NeuroImage Clinical (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • RePub (Erasmus University Rotterdam) (submittedVersion)
Funders
  • Dioraphte Foundation (09-02-03-00)
  • NWO (HCMI 056-13-018, 016130677, 05613010)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
Keywords
frontotemporal dementia, presymptomatic mutation carriers, MAPT mutations, GRN mutations, cerebral blood flow, arterial spin labeling, disease biomarkers, disease progression, familial frontotemporal dementia
MeSH terms
Progranulins, Adult, Aged, Cerebrovascular Circulation, Cross-Sectional Studies, Female, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Mutation, Neuropsychological Tests, Spin Labels, Statistics as Topic, tau Proteins, Intercellular Signaling Peptides and Proteins, Young Adult, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review